U.S. federal trademark · Serial No. 97106239 · Reg. No. 7020508
Drug for human use, namely, pharmaceutical preparation for the treatment of neuroinflammatory disease administered subcutaneously or intravenously to patients with amyotrophic lateral sclerosis
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.